These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2581456)

  • 1. Muscarinic inhibition of canine small intestinal motility in vivo.
    Fox JE; Daniel EE; Jury J; Robotham H
    Am J Physiol; 1985 May; 248(5 Pt 1):G526-31. PubMed ID: 2581456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P: a potent inhibitor of the canine small intestine in vivo.
    Fox JE; Daniel EE
    Am J Physiol; 1986 Jan; 250(1 Pt 1):G21-7. PubMed ID: 2417497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for muscarinic inhibitory neurotransmission in rodent small intestine.
    Nowak TV; Harrington B; Kalbfleisch JH
    J Pharmacol Exp Ther; 1989 Feb; 248(2):573-80. PubMed ID: 2465406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor effects of gastrin releasing peptide (GRP) and bombesin in the canine stomach and small intestine.
    Fox JE; McDonald TJ
    Life Sci; 1984 Oct; 35(16):1667-73. PubMed ID: 6548281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic M1 receptors stimulate a nonadrenergic noncholinergic inhibitory pathway in the isolated rat duodenum.
    Micheletti R; Schiavone A; Giachetti A
    J Pharmacol Exp Ther; 1988 Feb; 244(2):680-4. PubMed ID: 2450199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria.
    Cost M; Majewski H
    Br J Pharmacol; 1991 Apr; 102(4):855-60. PubMed ID: 1713109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic control mechanisms for immunoreactive motilin release and motility in the canine duodenum.
    Fox JE; Daniel EE; Jury J; Track NS; Chiu S
    Can J Physiol Pharmacol; 1983 Sep; 61(9):1042-9. PubMed ID: 6139157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of endogenous acetylcholine from a vascularly perfused rat stomach in vitro; inhibition by M3 muscarinic autoreceptors and alpha-2 adrenoceptors.
    Yokotani K; Okuma Y; Nakamura K; Osumi Y
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1190-5. PubMed ID: 7690397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic identification, activation and antagonism of two muscarine receptor subtypes in the lower esophageal sphincter.
    Gilbert R; Rattan S; Goyal RK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):284-91. PubMed ID: 6205136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta.
    Jaiswal N; Lambrecht G; Mutschler E; Tacke R; Malik KU
    J Pharmacol Exp Ther; 1991 Sep; 258(3):842-50. PubMed ID: 1716312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Brown JH; Goldstein D; Masters SB
    Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors.
    Rubanyi GM; McKinney M; Vanhoutte PM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):802-8. PubMed ID: 2435886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of muscarinic receptors involved in McN-A-343-induced effects on intestinal motility and heart rate in conscious dogs.
    Schiavone A; Sagrada A; Micheletti R; Giachetti A
    Br J Pharmacol; 1988 Jun; 94(2):566-72. PubMed ID: 2456119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galanin: an inhibitory neural peptide of the canine small intestine.
    Fox JE; McDonald TJ; Kostolanska F; Tatemoto K
    Life Sci; 1986 Jul; 39(2):103-10. PubMed ID: 2425211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cholinoreceptors in the rat urinary bladder by the use of agonists and antagonists of the cholinergic system.
    Adami M; Bertaccini G; Coruzzi G; Poli E
    J Auton Pharmacol; 1985 Sep; 5(3):197-205. PubMed ID: 2414301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptors on nerves and muscles in opossum esophagus muscularis mucosa.
    Daniel EE; Jury J; Bowker P
    Can J Physiol Pharmacol; 1987 Sep; 65(9):1903-7. PubMed ID: 2446726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor subtypes mediating the mucosal response to neural stimulation of guinea pig ileum.
    Carey HV; Tien XY; Wallace LJ; Cooke HJ
    Am J Physiol; 1987 Sep; 253(3 Pt 1):G323-9. PubMed ID: 2443017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.
    Black JW; Shankley NP
    Br J Pharmacol; 1985 Nov; 86(3):609-17. PubMed ID: 2415197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor subtypes involved in regulation of colonic motility in mice: functional studies using muscarinic receptor-deficient mice.
    Kondo T; Nakajima M; Teraoka H; Unno T; Komori S; Yamada M; Kitazawa T
    Eur J Pharmacol; 2011 Nov; 670(1):236-43. PubMed ID: 21924260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.